Synthetic Lethal Vulnerabilities in KRAS-Mutant Cancers
Author:
Publisher
Cold Spring Harbor Laboratory
Subject
General Biochemistry, Genetics and Molecular Biology
Reference134 articles.
1. Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers
2. Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
3. Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33
4. STK33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells
5. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular mechanisms of non-genetic aberrant peptide production in cancer;Oncogene;2024-05-27
2. Targeting NUPR1-dependent stress granules formation to induce synthetic lethality in KrasG12D-driven tumors;EMBO Molecular Medicine;2024-02-15
3. Deciphering the role of KRAS gene in oncogenesis: Focus on signaling pathways, genetic alterations in 3’UTR, KRAS specific miRNAs and therapeutic interventions;Critical Reviews in Oncology/Hematology;2024-02
4. CRISPRing KRAS: A Winding Road with a Bright Future in Basic and Translational Cancer Research;Cancers;2024-01-22
5. TooManyCellsInteractive: A visualization tool for dynamic exploration of single-cell data;GigaScience;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3